TMO vs VTR · P/E 24, rev $44.56B vs P/E 149, rev $4.92B
Thermo Fisher Scientific Inc (TMO) versus Ventas Inc (VTR) — a side-by-side from cached financials, not a winner call.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Ventas Inc (VTR) is a reit - healthcare facilities company listed on NYSE.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Latest reported VTR revenue for 2024-12-31 was $4.92B. Net income was $88.4M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
TMO currently screens at market cap $153.06B and trailing P/E 23.8. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
Not investment advice. Open the TMO and VTR stock pages for the full models.
Not investment advice.